What is Uresta?
Uresta operates at the intersection of medical device innovation and consumer wellness, providing a discreet, tampon-like solution designed to support the urethra and prevent leakage. By focusing on comfort and ease of use, the company addresses a pervasive quality-of-life issue for women, enabling greater physical freedom during daily activities. Its market position is defined by a commitment to safe, all-day wearability, effectively bridging the gap between clinical efficacy and consumer-grade accessibility in the pelvic health market.
How much funding has Uresta raised?
Uresta has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2025): $3M with participation from BDC
Key Investors in Uresta
BDC
BDC is a prominent financial institution dedicated to supporting Canadian entrepreneurs through specialized financing and advisory services, with a strong focus on technology-driven growth.
What's next for Uresta?
Following this major strategic investment, Uresta is expected to prioritize the expansion of its distribution channels and the acceleration of its market penetration strategy. The infusion of capital will likely support broader clinical validation efforts and the scaling of manufacturing capabilities to meet rising demand. As the company transitions into a more mature enterprise-level phase, stakeholders will be monitoring its ability to capture a larger share of the global incontinence management market while maintaining its reputation for high-quality, patient-focused health solutions.
See full Uresta company page
